Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alejandro Martín, MD
University of Salamanca
Principal Investigator - Ana Pilar González, MD
Hospital Central de Asturias
Principal Investigator - Andres Sánchez, MD
Hospital Virgen de la Arrixaca
Principal Investigator - Armando López, MD
Hospial Clínic de Barcelona
Principal Investigator - Carlos Grande, MD
Hospital Universitario 12 de Octubre
Principal Investigator - Cristina Barrenetxea, MD
Hospital Vall d'Hebrón
Principal Investigator - Cristina Castilla, MD
Hospital Morales Meseguer
Principal Investigator - Encarnación Monzó, MD
Hospital Arnau de Vilanova de Valencia
Principal Investigator - Eulogio Conde, MD
Hospital Marqués de Valdecilla
Principal Investigator - Fátima de la Cruz, MD
Hospital Virgen del Rocío
Principal Investigator - Isidro Jarque, MD
Hospital La Fe
Principal Investigator - Javier Briones, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator - Javier López, MD
Hospital Universitario Ramon y Cajal
Principal Investigator - Jorge Gayoso, MD
Gregorio Marañón Hospital
Principal Investigator - José Luis Bello, MD
Complejo Hospitalario Universitario de Santiago de Compostela
Principal Investigator - José Rifón, MD
Clínica Universitaria Navarra
Principal Investigator - Juan Manuel Sancho, MD
Germans Trias i Pujol Hospital
Principal Investigator - Luis Palomera, MD
Hospital Clínico de Zaragoza "Lozano Blesa"
Principal Investigator - Miguel Ángel Canales, MD
Hospital Universitario La Paz
Principal Investigator - Mª Dolores Caballero, MD
University of Salamanca
Principal Investigator - Mª José Ramírez, MD
Hospital Jerez de la Frontera
Principal Investigator - Mª José Rodríguez, MD
Hospital Universitario de Canarias
Principal Investigator - Mª José Terol, MD
Hospital Clínico de Valencia
Principal Investigator - Raquel del Campo, MD
Hospital Son Llátzer
Principal Investigator - Reyes Arranz, MD
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Principal Investigator - Rosario Varela, MD
Complejo Hospitalario Universitario de A Coruña
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Complejo Hospitalario Universitario de Santiago
Santiago, A Coruña, Spain
- H. de la Santa Creu I Sant Pau
Barcelona, Barcelona, Spain
- Hospital Clinic I Provincial
Barcelona, Barcelona, Spain
- Hospital Vall D´hebron
Barcelona, Barcelona, Spain
- H. U. Marqués de Valdecilla.
Santander, Cantabria, Spain
- Hospital de Jerez
Jerez de la Frontera, Cádiz, Spain
- H.U. 12 de Octubre,
Madrid, Madrid, Spain
- H.U. Gregorio Marañón,
Madrid, Madrid, Spain
- H.U. la Paz
Madrid, Madrid, Spain
- H.U. la Princesa
Madrid, Madrid, Spain
- Hospital Ramon Y Cajal
Madrid, Madrid, Spain
- Hospital Son Llátzer
Palma de Mallorca, Mallorca, Spain
- Hospital Universitario Virgen de Arrixaca
El Palmar, Murcia, Spain
- Clinica Universitaria de Navarra
Pamplona, Navarre, Spain
- Hospital Central de Asturias
Oviedo, Principality of Asturias, Spain
- H. Clínico Universitario de Salamanca
Salamanca, Salamanca, Spain
- Hospital Universitario de Canarias
Santa Cruz de Tenerife, Tenerife, Spain
- H. la Fe
Valencia, Valencia, Spain
- Hospital Arnau de Vilanova
Valencia, Valencia, Spain
- Hospital Clinico de Valencia
Valencia, Valencia, Spain
- Hospital Clínico Lozano Blesa
Zaragoza, Zaragoza, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 30 Nov 2015
- Completion
- 30 Nov 2015
- Last update posted
- 17 Feb 2016
- Registered enrollment
- 60
- Registry id
- NCT01296256
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.